Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
NCT00486980 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2008-01-30
Summary
This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.
Conditions
Interventions
- DRUG
-
Peramivir 150mg
- DRUG
-
Peramivir 300mg
Sponsors & Collaborators
-
BioCryst Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
NCT00958776 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
NCT00957996 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Dose Study of Peramivir for Influenza Treatment
NCT00297050 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
NCT01231620 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
NCT00453999 ·Status: COMPLETED ·Phase: PHASE2
-
Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections
NCT02665351 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza
NCT01056380 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
NCT02369159 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A
NCT04683406 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
NCT01068912 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)
NCT05818124 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Single Administration Intravenous Treatment for Influenza
NCT01375985 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza
NCT02603952 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
NCT05567783 ·Status: TERMINATED ·Phase: PHASE2
-
Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
NCT04982913 ·Status: COMPLETED ·Phase: PHASE1
-
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
NCT06573008 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
NCT01227421 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT02342249 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
NCT01793883 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intranasal INNA-051 for Prevention of COVID-19 in Adults
NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2
-
Zanamivir Versus Trivalent Split Virus Influenza Vaccine
NCT00784784 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection
NCT02293863 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
NCT01980966 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza
NCT05095545 ·Status: COMPLETED ·Phase: PHASE2